Preconditioning by subinotropic doses of ouabain in the langendorff perfused rabbit heart

Journal of Cardiovascular Pharmacology

Volumn 55, Issue 3, 2010, Pages 234-239

  Morgan, Eric E ^a   Li, Zhichuan ^a   Stebal, Cory ^a   Belliard, Aude ^a   Tennyson, Glen ^a   Salari, Bijan ^a   Garlid, Keith D ^b   Pierre, Sandrine V ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b PORTLAND STATE UNIVERSITY   (United States)

Author keywords

Cardiac inotropy; Heart; Na K ATPase; Ouabain; Preconditioning; Rabbit

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CARDIAC GLYCOSIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OUABAIN; PROTEIN KINASE B; PROTEIN KINASE C EPSILON; PROTEIN TYROSINE KINASE;

ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG MECHANISM; ENZYME ACTIVATION; EXPERIMENTAL MODEL; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; INOTROPISM; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY;

ANIMALS; CARDIOTONIC AGENTS; CELL DEATH; DISEASE MODELS, ANIMAL; MALE; MYOCARDIAL REPERFUSION INJURY; OUABAIN; RABBITS; SIGNAL TRANSDUCTION; SODIUM-POTASSIUM-EXCHANGING ATPASE; SPECIES SPECIFICITY; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 77951048705     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181ce5e14     Document Type: Article

References (37)

1. Akera T, Brody TM. The role of Na+, K+-ATPase in the inotropic action of digitalis. Pharmacol Rev. 1977;29:187-220.
2. Haas M, Askari A, Xie Z. Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. J Biol Chem. 2000;275:27832-27837.
3. Haas M, Wang H, Tian J, et al. Src-mediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J Biol Chem. 2002;277:18694-18702. (Pubitemid 34952426)
4. Kometiani P, Li J, Gnudi L, et al. Multiple signal transduction pathways link Na+/K+-ATPase to growth-related genes in cardiac myocytes. The roles of Ras and mitogen-activated protein kinases. J Biol Chem. 1998; 273:15249-15256. (Pubitemid 28272826)
5. Liu J, Tian J, Haas M, et al. Ouabain interaction with cardiac Na+/K+- ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations. J Biol Chem. 2000;275:27838-27844.
6. Liu L, Zhao X, Pierre SV, et al. Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes. Am J Physiol Cell Physiol. 2007;293:C1489-C1497. (Pubitemid 350085621)
7. Mohammadi K, Kometiani P, Xie Z, et al. Role of protein kinase C in the signal pathways that link Na+/K+-ATPase to ERK1/2. J Biol Chem. 2001; 276:42050-42056.
8. Pierre SV, Xie Z. The Na, K-ATPase receptor complex: its organization and membership. Cell Biochem Biophys. 2006;46:303-316. (Pubitemid 46202583)
9. Pierre SV, Yang C, Yuan Z, et al. Ouabain triggers preconditioning through activation of the Na+, K+-ATPase signaling cascade in rat hearts. Cardiovasc Res. 2007;73:488-496. (Pubitemid 46073947)
10. Xie Z. Ouabain interaction with cardiac Na/K-ATPase reveals that the enzyme can act as a pump and as a signal transducer. Cell Mol Biol (Noisy-le-grand). 2001;47:383-390.
11. Xie Z, Cai T. Na+-K+-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol Interv. 2003;3:157-168.
12. Xie Z, Kometiani P, Liu J, et al. Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem. 1999;274:19323-19328. (Pubitemid 129519362)
13. D'Urso G, Frascarelli S, Zucchi R, et al. Cardioprotection by ouabain and digoxin in perfused rat hearts. J Cardiovasc Pharmacol. 2008;52:333-337.
14. Ferrandi M, Molinari I, Barassi P, et al. Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238. J Biol Chem. 2004;279:33306-33314. (Pubitemid 39062978)
15. Inserte J. Triggering of cardiac preconditioning through Na+/K+-ATPase. Cardiovasc Res. 2007;73:446-447.
16. Pasdois P, Quinlan CL, Rissa A, et al. Ouabain protects rat hearts against ischemia-reperfusion injury via pathway involving src kinase, mitoKATP, and ROS. Am J Physiol Heart Circ Physiol. 2007;292:H1470-H1478. (Pubitemid 46377135)
17. Tian J, Gong X, Xie Z. Signal-transducing function of Na+-K+-ATPase is essential for ouabain's effect on [Ca2+]i in rat cardiac myocytes. Am J Physiol Heart Circ Physiol. 2001;281:H1899-H1907.
18. Tian J, Liu J, Garlid KD, et al. Involvement of mitogen-activated protein kinases and reactive oxygen species in the inotropic action of ouabain on cardiac myocytes. A potential role for mitochondrial K(ATP) channels. Mol Cell Biochem. 2003;242:181-187. (Pubitemid 36240544)
19. Wasserstrom JA, Aistrup GL. Digitalis: new actions for an old drug. Am J Physiol Heart Circ Physiol. 2005;289:H1781-H1793. (Pubitemid 41507322)
20. Quinlan CL, Costa AD, Costa CL, et al. Conditioning the heart induces formation of signalosomes that interact with mitochondria to open mitoKATP channels. Am J Physiol Heart Circ Physiol. 2008;295:H953-H961.
21. Hearse DJ, Humphrey SM, Garlick PB. Species variation in myocardial anoxic enzyme release, glucose protection and reoxygenation damage. J Mol Cell Cardiol. 1976;8:329-339.
22. Kim HD, Kim CH, Rah BJ, et al. Quantitative study on the relation between structural and functional properties of the hearts from three different mammals. Anat Rec. 1994;238:199-206.
23. Tanaka H, Namekata I, Nouchi H, et al. New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: diversity in the excitation-contraction mechanisms of the heart. J Pharmacol Sci. 2009;109:327-333.
24. Vidavalur R, Swarnakar S, Thirunavukkarasu M, et al. Ex vivo and in vivo approaches to study mechanisms of cardioprotection targeting ischemia/ reperfusion (i/r) injury: useful techniques for cardiovascular drug discovery. Curr Drug Discov Technol. 2008;5:269-278.
25. Ytrehus K. The ischemic heart-experimental models. Pharmacol Res. 2000;42:193-203.
26. Ezzaher A, Mougenot R, Baggioni A, et al. Inotropic effects of ouabain and Na, K-ATPase activity in failing rabbit hearts. C R Acad Sci III. 1995; 318:273-279.
27. Mohammadi K, Liu L, Tian J, et al. Positive inotropic effect of ouabain on isolated heart is accompanied by activation of signal pathways that link Na+/K+-ATPase to ERK1/2. J Cardiovasc Pharmacol. 2003;41:609-614. (Pubitemid 36373799)
28. Barbey O, Gerbi A, Robert K, et al. Immunological identification of Na, K-ATPase isoforms in nonfailing and failing myocardium. Ann N Y Acad Sci. 1997;834:656-657. (Pubitemid 28009149)
29. Shamraj OI, Grupp IL, Grupp G, et al. Characterisation of Na/K-ATPase, its isoforms, and the inotropic response to ouabain in isolated failing human hearts. Cardiovasc Res. 1993;27:2229-2237. (Pubitemid 24034739)
30. Kilgore KS, Friedrichs GS, Johnson CR, et al. Protective effects of the SOD-mimetic SC-52608 against ischemia/reperfusion damage in the rabbit isolated heart. J Mol Cell Cardiol. 1994;26:995-1006. (Pubitemid 24279515)
31. Ytrehus K, Liu Y, Tsuchida A, et al. Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol. 1994;267:H2383-H2390.
32. Jenkins DP, Pugsley WB, Yellon DM. Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction of stunning. J Mol Cell Cardiol. 1995;27:1623-1632.
33. Yasojima K, Kilgore KS, Washington RA, et al. Complement gene expression by rabbit heart: upregulation by ischemia and reperfusion. Circ Res. 1998;82:1224-1230. (Pubitemid 28311129)
34. Maixent JM, Gerbi A, Barbey O, et al. Dietary fish oil promotes positive inotropy of ouabain in the rat heart. Am J Physiol. 1999;277:H2290-H2297. (Pubitemid 30048149)
35. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev. 1999;79:609-634. (Pubitemid 29210931)
36. Lochner A, Genade S, Moolman JA. Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery. Basic Res Cardiol. 2003;98:337-346. (Pubitemid 37107661)
37. Arispe N, Diaz JC, Simakova O, et al. Heart failure drug digitoxin induces calcium uptake into cells by forming transmembrane calcium channels. Proc Natl Acad Sci U S A. 2008;105:2610-2615 (Pubitemid 351520561)